Skip to content
OpenCapital
Get started

CONMED CNMD Payments of Ordinary Dividends, Common Stock

Payments of Ordinary Dividends, Common Stock at other companies

TFX
TeleflexTFX
$15.05M-0.9%
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-35.6%
Enterprise value$1.89B-24.5%
P/E19.4×+5.5×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividendsCommonStock.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's payments of ordinary dividends, common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's payments of ordinary dividends, common stock?
CONMED (CNMD) reported payments of ordinary dividends, common stock of $0 in Q1 2026.
How has CONMED's payments of ordinary dividends, common stock changed year-over-year?
CONMED's payments of ordinary dividends, common stock decreased by 100.0% year-over-year, from $6.18M to $0.
What is the long-term trend for CONMED's payments of ordinary dividends, common stock?
Over 4 years (2021 to 2025), CONMED's payments of ordinary dividends, common stock has grown at a 1.6% compound annual growth rate (CAGR), from $23.26M to $24.75M.
What does payments of ordinary dividends, common stock mean?
The total cash outflow distributed to common shareholders as a return on their investment. This metric is a key indicator of the company's capital allocation strategy and its commitment to returning value to equity holders.